The Psychedelic Report

In this powerful episode of The Psychedelic Report, Dr. Dave Rabin sits down with John and Melissa King to explore the deeply personal and transformative journey of recovering from complex PTSD. John shares his path from uncovering repressed memories of childhood sexual trauma to rebuilding his identity, one hard-won insight at a time, with Melissa by his side as partner, advocate, and witness. As psychedelic medicines have demonstrated more promise to successfully address the burden of trauma than any other therapies discovered to date, John’s story emphasizes the tremendous potential of all those who could be supported by these powerful tools.Together, they open up about what it really means to recover from trauma: the loss of a former self, the courage to embrace vulnerability, and the importance of self-awareness and community support. From the tools that helped John—like bodybuilding, daily structure, and redefining internal narratives—to the moment he chose to live, this episode offers raw honesty and hope for anyone navigating the long road to healing.John’s story is one of pain, transformation, and ultimately empowerment. As he puts it: “This trauma doesn’t define me—it refines me.” Whether you're supporting someone with PTSD or walking your own healing path, this conversation reminds us that we all deserve the tools and the community to recover. And there are a whole lot more tools than you know about, Apollo Neuro being a primary one.Sponsor: Apolloneuro.comDeal With It: Living Well With PTSD by John King 📖 Learn more: https://drjohnaking.com/Web: https://thepsychedelic.report Instagram: https://www.instagram.com/drdavidrabin Twitter: https://twitter.com/DrDavidRabin More from Dr. Dave: https://www.drdave.io/

In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes renowned experts James Fadiman, PhD, and Jordan Gruber, JD, for a compelling conversation on the science and health significance of microdosing. Together, they explore the historical roots of psychedelics in America and their resurgence in modern medicine, shedding light on how these once-stigmatized substances are now being reexamined for their therapeutic potential.Gain a deeper understanding of what microdosing is, how it works in the brain and body, and the optimal protocols for safe and effective use. This discussion highlights the role of microdosing in enhancing neuroplasticity, reducing inflammation, and supporting mental health—especially for those grappling with treatment-resistant depression. With a mix of scientific insight, real-world experiences, and emerging research, this episode offers valuable takeaways for both newcomers and seasoned explorers of psychedelics.Microdosing for Health, Healing, and Enhanced Performance: http://MicrodosingBook.comTo dive even deeper, check out Your Symphony of Selves by Fadiman and Gruber, and check out our previous discussion on the TPR about microdosing and multiple personalities.Published Microdosing book related interviews and podcasts:https://www.microdosingbook.com/eventsWeb: https://thepsychedelic.reportTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Psychedelic whole plant medicines have been used for thousands of years, yet there is very little modern research surrounding them. Despite this, various plants have been used to heal and transform our mental states, and according to some beliefs, as a way to open the heart and spirit, and even treat mental and physical illnesses. In this episode, Dr. Dave Rabin is sitting down with Stephanie Wang, CEO of KA! Empathogenics, to explore the history, uses, and potential mental health benefits of Kanna. Kanna is a fully legal and biochemically fascinating plant originating in South Africa. Together, they discuss the potential to enhance resilience, elevate mood, and promote emotional healing. How does it compare to MDMA? What can we learn from traditional plant wisdom? Join us as we dive into the evolving science and culture of psychedelics, revealing new pathways to well-being.Instagram: https://www.instagram.com/stephaniewang5d Web: https://kaempathogenics.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabin Web: https://www.drdave.io/

In this episode, Dr. Dave Rabin sits down with Jamie Wheal, bestselling author of Stealing Fire, and celebrated author of Recapture the Rapture, to explore the evolving role of psychedelics in society, from their historical significance in the 1960s counterculture to their emerging therapeutic applications today. They deep dive into consciousness, psychedelics, the concept of ‘rapture’, the neuroscience of courage, and insights from Eric Kandel on how evolutionary learning mechanisms shape all decision-making. Examining the contrast between ancient plant medicine traditions and modern high-potency psychedelics, they highlight the challenges of integration, the risks of dependency, and the importance of preparation and support in therapeutic settings. They also address the commodification of psychedelics, the necessity of a sacramental approach, and the deeper spiritual and communal significance of these substances. Ultimately, they emphasize self-discovery, the acceptance of uncertainty, and the requirement for unity and responsible engagement with psychedelics to foster healing and collective transformation. Article: https://www.nytimes.com/2025/02/04/health/fda-mdma-psychedelic-therapy-psymposia.htmlBook: https://www.recapturetherapture.com/Instagram: https://www.instagram.com/jamiewheal/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/The Immortality Key by Brian Muraresku: https://brianmuraresku.com/

In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Skippy Mesirow. They delve into the evolving landscape of psychedelic medicine, discussing recent setbacks in the FDA's decision regarding MDMA-assisted therapy and the implications for the broader psychedelic community. Skippy shares his journey as a facilitator in the psychedelic space, offering insights from his work in Colorado's movement and innovative approaches in Aspen. Together, they discuss the vital role of community, compassion, and collaboration in advancing therapies, reflect on the healing and creative energy of Burning Man, and emphasize the importance of unity among advocates for decriminalization and legalization. Tune in for an inspiring call to action and valuable insights from two dedicated leaders in the field.Instagram: https://www.instagram.com/skippymesirow/Web: https://www.electedleaderscollective.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

What if true healing involves more than just the physical body? Join Dr. Dave Rabin in an inspiring conversation with filmmaker and author Kelly Gores, where they explore the intricate connection between mind, body, and spirit through the transformative potential of psychedelics, spirituality, and self-awareness. They delve into the field of epigenetics, explaining how our environment and experiences can turn genes on and off, directly impacting health outcomes. With powerful stories like Anita Morjani's near-death experience, Kelly illustrates how a change in perception can open pathways to profound healing and connection to our true selves.This episode also covers the “illusion of separation” that often leads to loneliness and fear, and how psychedelics can help dissolve this barrier, reconnecting us to a sense of universal love and oneness. Kelly shares her own practices of intention-setting and gratitude as transformative tools, showing how each of us holds the power to shape our reality. Tune in to uncover how embracing a holistic approach to healing can unlock resilience, empower us to overcome challenges, and bring us back to our authentic selves.Instagram: https://www.instagram.com/kellygores/Web: https://www.healwithkelly.co/about.htmlTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Is our time quickly becoming the era of “psychedelic McCarthyism”? If we’re not careful, that’s where it looks like we’re heading… In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with Hamilton Morris for an in-depth discussion on the recent controversy surrounding MDMA-assisted therapy and the FDA's pivotal August 9th decision. Together, they address the backlash against MAPS/Lykos and how misinformation has fueled public skepticism and prevented this safe and powerful treatment from getting to millions of patients suffering from PTSD. Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation. This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.Instagram: https://www.instagram.com/hamiltonmorris/Hamilton’s Pharmacopeia: https://www.vicetv.com/en_us/show/hamiltons-pharmacopeiaThe Hamilton Morris Podcast: https://hamiltonmorris.buzzsprout.com/1870388Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

In this episode, Dr. Dave Rabin and Dr. Jonathan Edwards tackle the controversial topic of ketamine in light of the tragic death of actor Matthew Perry. Together, they explore the safety profile of ketamine, its legitimate uses in treating depression and suicidal ideation, and dispel misinformation regarding its association with Perry's passing.Dr. Edwards, a leading expert in ketamine-assisted therapy and author of The Revolutionary Ketamine, offers his insights on the pressing need for effective mental health treatments. As suicide rates continue to rise, particularly among young people, this episode emphasizes the potential of ketamine as a life-saving treatment and the importance of therapy in conjunction with medication.Tune in to gain a deeper understanding of ketamine’s role in mental health and how it can potentially save lives.The Revolutionary Ketamine on AmazonStopping Pain: A Revolutionary Approach on AmazonDr. Jonathan Edwards' WebsiteSubscribe to Dr. Edwards' SubstackWeb: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

How do we optimize our bodies and our brains for learning new things? In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes back nutritional biochemist Shawn Wells to explore the often-overlooked topic of post-psychedelic supplementation. They discuss how to optimize the benefits of psychedelic experiences and ensure that the transformations achieved during these journeys can last longer. Shawn shares his expertise on various supplements, nutrients, and dietary strategies that can enhance neuroplasticity, support mental health, and promote overall well-being after a psychedelic experience. The conversation covers essential topics such as hydration, the role of adaptogens, the importance of neurotransmitter repletion, and the impact of diet on recovery.Tune in for valuable insights from leading experts in the field of Psychedelic Medicine.Optimizing Psychedelic Medicine Experiences with Shawn WellsWeb: https://shawnwells.com/Instagram: https://www.instagram.com/shawnwellsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode, Dr. Dave Rabin discusses the impact of the FDA's decision, the potential delays in accessing this crucial treatment, and the unethical behavior of certain organizations influencing the FDA. Dr. Rabin is joined by Jon Lubecky, a retired army sergeant and Veteran who took part in MAPS MDMA therapy trials, as he discusses the implications of this rejection and emphasizes the need for ongoing advocacy and hope for eventual approval. The episode also addresses the unethical behavior of Symposia, an organization accused of falsifying information to the FDA to obstruct MDMA therapy approval. Additionally, former Symposia member David Nichols reveals serious ethical violations within the organization, raising questions about their motives and funding. Through these discussions, the episode highlights the critical need for transparency, ethical practices, and continued efforts to ensure access to psychedelic treatments for those in need.Rachel Nuwer’s Scientific American Article: https://www.scientificamerican.com/article/fdas-rejection-of-mdma-psychotherapy-for-trauma-draws-criticism-from/Jon Lubecky’s Conversation with David Nickles on Breaking Points: https://www.youtube.com/watch?v=lttFB0c0cAoWeb: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193

In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school  and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.Brain Health in Exeter, New Hampshire (http://www.brain-health.co)Psychiatric Times (http://www.psychiatrictimes.com)https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthorhttps://www.linkedin.com/in/jjmillermd/https://www.linkedin.com/company/psychiatric-times/www.apolloneuro.comFDA petition for MDMA-assisted therapyhttps://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/

In this episode, Dr. Dave Rabin MD, PhD is joined by Dr. Geoff Bathje PhD who authored an article published on July 19, 2024 in Chacruna entitled: “The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy.”Dr. Bathje and Dr. Rabin discuss the recent FDA Advisory Committee vote on MDMA-assisted therapy for PTSD, which surprisingly and wrongfully concluded that the benefits do not outweigh the risks. This conversation deep dives into Dr. Bathje’s report on how Psymposia, what appears to be a group of fringe radicals, negatively biased the FDA committee's vote on June 4 by writing letters with false and misleading claims in an attempt to prevent the clearance of MDMA for PTSD. Why would anyone not only want to prevent clearance of MDMA therapy for Veterans, but see themselves as heroes for doing so? Find out all that and more in this weeks episode of The Psychedelic Report.The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy by Dr. Geoff Bathje: https://chacruna.net/unbelievable-claims-of-psymposia-about-maps-and-mdma-assisted-therapy/Web: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193

In this episode of The Psychedelic Report, Jesse Gould, Veteran Army Ranger and Founder of the Heroic Hearts Project, joins Dr. Dave Rabin to explore the implications of the recent FDA advisory committee vote on MDMA-assisted therapy for Veterans with PTSD. They highlight concerns over the influence of non-objective groups on the committee's decision and discuss the potential impact on millions of individuals seeking effective treatment for mental health challenges.Join the conversation as they explore the implications of disrupting the progress of a groundbreaking treatment and the importance of advocating for evidence-based therapies. Learn how you can get involved and make your voice heard to support the advancement of MDMA-assisted therapy for those who need it most.To take action and stay informed, visit Heroic Hearts and sign up for updates on upcoming initiatives. Let's come together to ensure access to life-changing treatments for Veterans and individuals suffering from PTSD.Don't miss this insightful discussion on the intersection of medicine, advocacy, and the future of psychedelic therapies. Subscribe to The Psychedelic Report for more thought-provoking episodes on the latest developments in psychedelic medicine and healing.FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193Web: https://heroicheartsproject.org/our-story/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this compelling episode of The Psychedelic Report, Dr. Dave Rabin delves into the evolving landscape of psychedelic-assisted therapies with special guest Jon Lubecki, a veteran and prominent advocate for such treatments in Ukraine. The discussion centers on the recent FDA advisory committee setback, which resulted in a 10 to 1 vote against MDMA-assisted therapy due to lingering concerns about its safety and efficacy, particularly in post-treatment activities like driving. Jon provides a nuanced analysis of the hearing, pointing out significant conflicts of interest among some opponents who failed to disclose their affiliations with competing therapies like psilocybin and ketamine. He also examines the critical role of influential organizations such as ICER and Symposia, whose biased reports have swayed public and regulatory opinions against MDMA trials. With a fervent focus on the broader implications for mental health, especially for veterans suffering from PTSD, Jon underscores the inadequacy of current treatments and the transformative potential of MDMA-assisted therapy. He shares his personal journey from struggling with PTSD to becoming a leading advocate, passionately calling for the democratization of access to these promising therapies, transcending political and social boundaries.Instagram: https://www.instagram.com/jonathanlubecky/Web: www.mdmaptsd.orgTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.comCongressman Dan Crenshaw speaks out on the MDMA-assisted therapy controversy and the anti-Veteran agenda : https://www.instagram.com/reel/C8zsu2Wu7M0/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193

In the latest episode of The Psychedelic Report, Dr. Dave Rabin shares the latest news on the MDMA-Assisted Therapy trials evaluation by the FDA Advisory Committee from June 4, who voted a surprising 10-1 that the risks of this breakthrough treatment outweigh the benefits. This was particularly astonishing to clinicians and researchers as described by Rachel Nuwer in her latest article in the BBC published on June 20. We’ll take a deep dive into this article and the discussion of safety and risks of MDMA-Assisted Therapy, followed by an enlightening conversation with award-winning author Tucker Max about his personal journey achieving a greater sense of safety with psychedelic-assisted therapy. Tucker discusses the importance of safety and integration practices in maximizing the benefits of psychedelic experiences. He emphasizes the role of journaling, psychotherapy, and lifestyle changes in supporting the integration process and facilitating personal growth. Tucker's journey highlights the profound impact of psychedelics on mental health, self-discovery, and relationships.Don't miss this insightful episode, where real-life experiences and expert perspectives converge to explore the healing potential of psychedelic medicines. Tune in now to embark on a journey of self-discovery and transformation with Tucker Max.Web: https://www.tuckermax.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.comTucker’s Books: https://www.tuckermax.com/books/#:~:text=Tucker%20Max's%20first%20three%20books,success%20has%20meant%20his%20success.Article: FDA advisors voted against MDMA therapy – researchers are still fighting for ithttps://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-itYour Brain Explained Episode 1 - The MDMA Breakthrough: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=0377e20f02ed481dRachel Nuwer’s NYT article breaking the study findings: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.htmlNature Medicine MDMA trial science article 1: https://www.nature.com/articles/s41591-021-01336-3Nature Medicine MDMA trial science article 2: https://www.nature.com/articles/s41591-023-02565-4Special episode of The Tim Ferriss Show with Dr. Dave Rabin on MDMA Therapy: https://open.spotify.com/show/5qSUyCrk9KR69lEiXbjwXMFood and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193

In this compelling episode of The Psychedelic Report, Dr. Dave Rabin is joined by esteemed journalist Rachel Nuwer, renowned for breaking the pivotal story on the Phase 3 MDMA-assisted therapy trials for PTSD in The New York Times. Together, they delve into the recent contentious votes from the FDA Pharmacologic Advisory Committee, which advised against approving MDMA-assisted therapy despite robust evidence from clinical trials. Rachel provides an insider's perspective on the committee's decision, expressing disappointment over the unreasonably high standards applied to MDMA-assisted therapy compared to other psychiatric medications. She and Dr. Rabin discuss the committee's focus on issues like demographic representation and the integration of therapy with MDMA treatment, arguing that these criticisms overlook the proven benefits of MDMA in enhancing psychotherapy outcomes.The episode highlights the need for better education on psychedelic therapy within the medical community and critiques the media's role in spreading public misconceptions. Rachel and Dr. Rabin emphasize the potential of MDMA-assisted therapy to revolutionize PTSD treatment, especially for Veterans and other underserved populations. Despite the setback, they remain hopeful that the scientific evidence and patients’ needs will ultimately prevail.Overall, the conversation underscores the importance of accurate reporting and increased awareness to advance psychedelic therapies and build public trust in these innovative treatments.Your Brain Explained - Can We Cute Mental Illness? The MDMA StoryApple: https://podcasts.apple.com/us/podcast/your-brain-explained/id1693658383?i=1000617879818Spotify: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=fd8c315823854dadRachel Nuwer’s Breaking News on MDMA Phase 3 Trials Results in the NYT: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.htmlRachel Nuwer’s book I Feel Love: MDMA and the Quest for Connection in a Fractured World https://www.goodreads.com/book/show/62039306-i-feel-loveTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode of The Psychedelic Report, Dr. Dave Rabin explores the nexus of nutrition, supplementation, and optimizing psychedelic medicine experiences with Shawn Wells, an expert in diet, nutrition, and biochemistry. Shawn discusses the transformative impact of psychedelics on his life and emphasizes the importance of practices like fasting and dietary restriction to establish an optimal physiological baseline for meaningful journeys. They discuss how fasting can induce a ketogenic state, potentially enhancing neuroplasticity during psychedelic experiences. This conversation emphasizes the significance of preparation, both physically and mentally, for psychedelic experiences, highlighting the importance of adaptability, stress tolerance, and learning. Web: https://shawnwells.com/Instagram: https://www.instagram.com/shawnwellsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode of The Psychedelic Report, Dr. Dave Rabin and Dr. Amy Killen delve into the profound correlation between sexuality, intimacy, and longevity. Dr. Killen, a physician, presents compelling research demonstrating that regular sexual activity is associated with reduced mortality rates, particularly in men, attributing this effect to the physiological impact of sexual experiences, including the release of neurotransmitters like dopamine, endorphins, serotonin, and oxytocin. They advocate for a comprehensive approach to sexual education, emphasizing self-exploration, effective communication, and the destigmatization of pleasure. This episode addresses societal taboos around sexuality and underscores the importance of prioritizing sexual health in healthcare practices. Overall, they challenge listeners to adopt a more open-minded and holistic perspective on sexuality, recognizing its profound impact on overall well-being and quality of life.Web: https://dramykillen.com/Instagram:https://www.instagram.com/dr.amybkillen/Facebook: https://www.facebook.com/DrAmyBKillen/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How can individuals improve their understanding of their capabilities and potential, particularly in the context of stress management and mindfulness practices?In this episode, Dr. Dave Rabin interviews Jeff Krasno, founder of Commune and a prominent figure in the health and wellness community, joins the discussion on stress, delineating between chronic distress and beneficial stress rooted in evolutionary pressures. Through Jeff's curated protocols, including intermittent fasting, cold therapy, and social experiments, listeners gain insight into harnessing the power of good stress to enhance physiological and psychological health. The conversation delves into the physiological benefits of good stress, the importance of optimal stress dosage, and the parallel between building psychological resilience and strengthening the immune system. Jeff emphasizes the role of attention control in shaping reality and advocates for meditation and mindfulness practices to cultivate it. The episode concludes with a reflection on embracing discomfort and life's uncertainties, including death, as avenues for growth and self-discovery through meditation and psychedelic exploration. Listeners can find Jeff Krasno on the Commune podcast and Instagram, with his course on good stress available on Commune's website, reflecting his mission to democratize access to transformative practices. Web: https://www.jeffkrasno.com/commune-podcastInstagram: https://www.instagram.com/jeffkrasno/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How can we improve our self-awareness and enter altered states of consciousness to live more fully? Join Dr. Dave Rabin and Dave Asprey as they delve into a fascinating discussion on various methods for accessing altered states of consciousness and enhancing self-awareness. They explore practices such as breathwork, neurofeedback, psychedelics, tantra, and conscious kink, among others, emphasizing the diverse range of tools available for personal growth and transformation.Dave Asprey shares profound insights into the process of resetting trauma and the importance of gratitude and forgiveness in healing. He explains that forgiveness is not about condoning the actions of others but about releasing reactivity and cultivating inner peace. Gratitude, often overlooked in therapeutic practices, is highlighted as a crucial step towards self-trust and personal growth.This episode addresses common concerns about personal transformation and reassures listeners that growth and change are natural processes that can lead to greater happiness and fulfillment.Web: https://40yearsofzen.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com